Home
Market Capitalization of Ind-swift Ltd

Ind-Swift Ltd
NSE: INDSWFTLTD
Market Cap
Key Highlights
- The Market Cap of Ind-Swift Ltd is ₹ 69.33 crore as of 27 Mar 25 .
- The Latest Trading Price of Ind-Swift Ltd is ₹ 12.8 as of 27 Mar 15:30 .

Ind-Swift Ltd
NSE: INDSWFTLTD
Share Price
Market Price of Ind-Swift Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
27 Mar 2025 | 12.8 |
26 Mar 2025 | 13.4 |
25 Mar 2025 | 14.07 |
24 Mar 2025 | 14.7 |
21 Mar 2025 | 14.43 |
20 Mar 2025 | 14.48 |
19 Mar 2025 | 14.14 |
18 Mar 2025 | 13.88 |
17 Mar 2025 | 13.54 |
13 Mar 2025 | 14.18 |
SWOT Analysis Of Ind-Swift Ltd
BlinkX Score for Ind-Swift Ltd
Asset Value vs Market Value of Ind-Swift Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Ind-Swift Ltd
Historical P/E Ratio of Ind-Swift Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Ind-Swift Ltd
Historical Revenue of Ind-Swift Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Ind-Swift Ltd
Historical EBITDA of Ind-Swift Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Ind-Swift Ltd
Historical Net Profit of Ind-Swift Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Ind-Swift Ltd
Dividend Payout Over Time
About Ind-Swift Ltd
- Ind-Swift Limited (ISL) is an India-based pharmaceutical company.
- The Company is engaged in the manufacturing and marketing of pharmaceutical finished dosage.
- The products manufactured by the company include cephalosporins, quinolones, aminoglycosides, macrolides, chloramphenicol, tetracyclines, sulphonamides, antianaerobics and anti-fungals. The company manufactures various dosage forms, including oral solutions and suspensions; dry syrups and hard gelatin capsules; tablets; dermatologicals comprising creams, ointments, and gels; eye and ear drops; and injectables.
- The company, through their different divisions, markets formulations focusing on the needs of various therapeutic segments, such as diabetology, cardiovascular, anesthesiology, oncology, ophthalmology, neuropsychiatry, gynecology, pediatric, ENT, surgery, internal medicine, dermatology, urology, cardiology, and dental specialty.
Ind-Swift Ltd News Hub
Ind-Swift consolidated net profit rises 1096.61% in the June 2024 quarter
Net profit of Ind-Swift rose 1096.61% to Rs 28.24 crore in the quarter ended June 2024 as against Rs
Read more
14 Aug 24
Ind-Swift to convene board meeting
Ind-Swift will hold a meeting of the Board of Directors of the Company on 13 August 2024. Powered by
Read more
02 Aug 24
Ind-Swift to conduct AGM
Ind-Swift announced that the Annual General Meeting (AGM) of the company will be held on 30 Septembe
Read more
03 Sept 24
Ind-Swift AGM scheduled
Ind-Swift announced that the Annual General Meeting (AGM) of the company will be held on 30 Septembe
Read more
03 Sept 24